Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluation of customized treatment according to BRCA1 assessment in patients with advanced gastric cancer
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A | Active Comparator | FLOT Regimen |
|
| Group B | Experimental | FLO Regimen or FLOT Regimen |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| FLOT Regimen | Drug | FLOT Regimen: 5-fluorouracil, Oxaliplatin, Docetaxel |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Progression-free Survival | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Overall Survival | 12 months | |
| Response Rate | 12 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Baorui Liu, MD, PHD | Contact | (86)13770621908 | baoruiliu@nju.edu.cn | |
| Jia Wei, MD, PHD | Contact | (86)13951785234 | weijia01627@hotmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Baorui Liu, MD, PHD | Drum Tower Hospital, Nanjing University Medical School | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| FLO Regimen or FLOT Regimen |
| Drug |
FLO Regimen: 5-fluorouracil, Oxaliplatin FLOT Regimen: 5-fluorouracil, Oxaliplatin, Docetaxel |
|
| ID | Term |
|---|---|
| D013274 | Stomach Neoplasms |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D013272 | Stomach Diseases |
Not provided
Not provided